inflsp | 13685
Infliximab (Remicade®), level
Status
| Material |
|
||
|---|---|---|---|
| Stability |
Stability
4 weeks / 2-8°C; 1 year / -20°C
|
||
| Duration | 1 - 2 weeks | ||
| Frequency | 1 x per week | ||
| Method | Enzyme Linked Immuno Sorbent Assay (ELISA) |
Price/Rate
| Price |
Price
CHF 49.50
|
|---|---|
| Rate |
Rate
49.50 TP
|
| AL Position | 1470.00 |
| Immunsuppressiva der SL/ALT |
Executing laboratory
| External laboratory |
|---|
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| 0.5 - 6 mg/L | f+m |
